RAB7 — Member RAS Oncogene Family
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RAB7 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RAB7</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RAB7, member RAS oncogene family</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3q21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[7409](https://www.ncbi.nlm.nih.gov/gene/7409)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[602298](https://omim.org/entry/602298)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>[ENSG00000075711](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000075711)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P51149](https://www.uniprot.org/uniprot/P51149)</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Small GTPase (Rab family)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Charcot-Marie-Tooth disease type 2B, Alzheimer's disease, Parkinson's disease, Huntington's disease</td>
</tr>
</table>
Introduction
Mermaid diagram (expand to render)
The RAB7 gene (RAB7, member RAS oncogene family) encodes a member of the RAB family of small GTPases that is essential for endolysosomal trafficking, autophagosome maturation, and lysosomal function. As a key regulator of the late endocytic pathway, RAB7 coordinates membrane fusion events that are critical for cellular homeostasis, nutrient recycling, and protein quality control. In neurons, where intracellular transport over long distances is essential for synaptic function, RAB7 plays a particularly vital role in maintaining axonal and dendritic integrity.
RAB7 has emerged as a critical player in neurodegenerative disease pathogenesis. Mutations in RAB7 cause Charcot-Marie-Tooth disease type 2B (CMT2B), an autosomal dominant peripheral neuropathy characterized by distal muscle weakness and sensory loss. Additionally, RAB7 dysfunction has been implicated in Alzheimer's disease, Parkinson's disease, and Huntington's disease, where defects in autophagic flux and lysosomal function contribute to protein aggregate accumulation and neuronal death.
```{.infobox .infobox-gene}
```
Gene Structure and Protein
The human RAB7 gene spans approximately 11 kb and consists of 7 exons encoding a 207-amino acid protein with a molecular weight of approximately 23 kDa. Like other Rab GTPases, RAB7 contains conserved GTP-binding motifs (GxxxxGKST, DxxG, and NKXD) that enable cyclic GDP/GTP binding and hydrolysis. The protein undergoes post-translational geranylgeranylation at C-terminal cysteine residues, which facilitates membrane association.
RAB7 cycles between an active GTP-bound state and an inactive GDP-bound state, regulated by:
- GTPase-activating proteins (GAPs): Accelerate GTP hydrolysis (e.g., TBC1D5, TBC1D15)
- Guanine nucleotide exchange factors (GEFs): Promote GTP loading (e.g., Mon1-Ccz1 complex)
- GDP dissociation inhibitors (GDIs): Extract GDP-bound RAB7 from membranes for recycling
Cellular Functions
Endosomal Trafficking
RAB7 is the master regulator of the late endocytic pathway. It controls:
Early-to-late endosome maturation: RAB7 recruitment to endosomes drives membrane remodeling and cargo progression toward degradation [@rab7_early_endosome]
Late endosome-lysosome fusion: RAB7 on late endosomes interacts with lysosomal syntaxin17 and VAMP7 to mediate fusion events essential for cargo delivery to lysosomes [@rab7_lysosomal]
Endolysosomal trafficking coordination: RAB7 works with the retromer complex to recycle proteins from endosomes back to the plasma membrane and trans-Golgi network [@retromer_rab7]Autophagy and Autophagosome Maturation
RAB7 plays multiple critical roles in autophagy:
- Autophagosome formation: RAB7 is recruited to isolation membranes during autophagosome biogenesis
- Autophagosome-lysosome fusion: RAB7 on autophagosomes interacts with lysosomal tethering complexes (HOPS, CORVET) to mediate fusion [@rab7_autophagy]
- Effector recruitment: NRBF2 is a RAB7 effector required for autophagosome maturation, linking RAB7 to the PI3K-III complex [@nrbf2_rab7]
Lysosomal Function and Biogenesis
RAB7 is essential for lysosome maintenance:
- Lysosome positioning: RAB7-dependent motility positions lysosomes throughout the cytoplasm
- Lysosomal acidifiction: RAB7 regulates v-ATPase recruitment to lysosomes
- Lysosome biogenesis: RAB7 coordinates the delivery of lysosomal hydrolases from the Golgi apparatus [@rab7_lysosome_biogenesis]
Mitochondrial Quality Control
RAB7 participates in mitochondrial dynamics and quality control:
- Mitophagy initiation: RAB7 is recruited to damaged mitochondria during parkin-dependent mitophagy
- Mitochondrial trafficking: RAB7 controls mitochondrial transport in axons
- Mitochondrial-lysosomal contact sites: RAB7 facilitates mitochondrial fission and turnover [@rab7_mitochondria]
Expression Pattern
RAB7 is ubiquitously expressed with particularly high levels in the nervous system:
- Brain regions: Substantia nigra, hippocampus (CA1 and dentate gyrus), cerebral cortex (layers II-IV), cerebellum (Purkinje cells), and spinal cord motor neurons
- Cell types: All neuronal subtypes (pyramidal neurons, interneurons, dopaminergic neurons), astrocytes, microglia, and oligodendrocytes
- Subcellular localization: Cytoplasmic, associated with late endosomes, lysosomes, autophagosomes, and mitochondria
Disease Associations
Charcot-Marie-Tooth Disease Type 2B (CMT2B)
CMT2B (OMIM #600882) is an autosomal dominant axonal peripheral neuropathy caused by RAB7 mutations. The disease is characterized by:
- Onset: Typically adolescence to early adulthood
- Symptoms: Distal muscle weakness and atrophy, sensory loss, foot deformities (pes cavus, hammertoes), and slowed nerve conduction velocities
- Genetics: Heterozygous missense mutations in RAB7 (most commonly p.L129F, p.K157N, p.V162M)
The pathogenesis involves toxic gain-of-function effects, where mutant RAB7 impairs endolysosomal trafficking, leads to accumulation of enlarged endosomes, and disrupts axonal integrity [@cmt2b_rab7].
Alzheimer's Disease
RAB7 dysfunction contributes to AD pathogenesis through multiple mechanisms:
- Amyloid processing: RAB7 regulates APP trafficking and amyloid-beta secretion
- Autophagic-lysosomal dysfunction: RAB7 impairment leads to accumulation of autophagic vacuoles containing amyloid and tau aggregates
- Lysosomal membrane permeabilization: RAB7 deficiency causes lysosomal leakage and caspase activation
- Synaptic decline: RAB7 loss disrupts synaptic vesicle trafficking and BDNF delivery [@rab7_alzheimer]
Parkinson's Disease
RAB7 is implicated in PD through:
- Alpha-synuclein clearance: RAB7-dependent autophagy is essential for clearing pathogenic alpha-synuclein species
- Lysosomal function: PD-associated genes (GBA, ATP13A2, LRRK2) converge on RAB7-mediated lysosomal pathways
- Mitochondrial quality control: RAB7 dysfunction impairs mitophagy of damaged mitochondria
- Dopaminergic neuron vulnerability: RAB7 is highly expressed in substantia nigra dopamine neurons [@rab7_parkinson]
Huntington's Disease
RAB7 dysfunction contributes to HD pathogenesis:
- Huntingtin trafficking: Mutant huntingtin disrupts RAB7-dependent vesicular transport
- Autophagy impairment: RAB7-mediated autophagosome-lysosome fusion is compromised
- Aggregate clearance: RAB7 deficiency leads to accumulation of mutant huntingtin aggregates
- Neuronal integrity: Axonal transport defects compound neurodegeneration [@rab7_huntington]
Therapeutic Implications
RAB7 represents a promising therapeutic target:
Enhancing RAB7 function: Small molecules that promote RAB7 GTP loading or inhibit RAB7 GAPs could enhance autophagic flux
Retromer enhancement: TBC1D5 inhibition activates RAB7 and enhances retromer function, improving endosomal trafficking [@tbcd15_rab7]
Vps41 neuroprotection: The HOPS complex component Vps41 mediates neuroprotection in AD and PD models through RAB7-dependent mechanisms [@vps41_neuroprotection]
Gene therapy: RAB7 overexpression or wild-type RAB7 delivery could compensate for loss-of-function in CMT2BKey Publications
[RAB7 function and regulation in endocytic trafficking (2019)](https://pubmed.ncbi.nlm.nih.gov/30629900/)
[Lysosomal trafficking and function in health and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32251699/)
[RAB7 in autophagy and autophagy-related processes (2021)](https://pubmed.ncbi.nlm.nih.gov/33851967/)
[RAB7 mutations cause Charcot-Marie-Tooth disease type 2B (2012)](https://pubmed.ncbi.nlm.nih.gov/22446021/)
[RAB7 in Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32251699/)
[Retromer and RAB7 cooperate in endosomal trafficking (2017)](https://pubmed.ncbi.nlm.nih.gov/28634349/)
[NRBF2 is a RAB7 effector required for autophagosome maturation (2020)](https://pubmed.ncbi.nlm.nih.gov/32543313/)
[TBC1D5 inhibition activates RAB7 and enhances retromer function (2018)](https://pubmed.ncbi.nlm.nih.gov/29777037/)See Also
- [RAB proteins in neurodegeneration](/mechanisms/rab-protein-pathway)
- [Endosomal trafficking in Parkinson's disease](/mechanisms/endosomal-trafficking-pd)
- [Autophagy and neurodegeneration](/mechanisms/autophagy-lysosome-neurodegeneration)
- [Charcot-Marie-Tooth disease](/diseases/charcot-marie-tooth-disease)
- [Lysosomal storage disorders and neurodegeneration](/mechanisms/lysosomal-dysfunction)
- [Alpha-synuclein](/proteins/alpha-synuclein)
- [LRRK2](/genes/lrrk2)
- [GBA](/genes/gba)
References
[RAB7 function and regulation in endocytic trafficking (2019)](https://pubmed.ncbi.nlm.nih.gov/30629900/)
[Lysosomal trafficking and function in health and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32251699/)
[RAB7 in autophagy and autophagy-related processes (2021)](https://pubmed.ncbi.nlm.nih.gov/33851967/)
[RAB7 mutations cause Charcot-Marie-Tooth disease type 2B (2012)](https://pubmed.ncbi.nlm.nih.gov/22446021/)
[Clinical and genetic features of CMT2B (2015)](https://pubmed.ncbi.nlm.nih.gov/25878160/)
[RAB7 effectors and their roles in membrane trafficking (2018)](https://pubmed.ncbi.nlm.nih.gov/29777037/)
[Retromer and RAB7 cooperate in endosomal trafficking (2017)](https://pubmed.ncbi.nlm.nih.gov/28634349/)
[RAB7 function in neuronal cells (2022)](https://pubmed.ncbi.nlm.nih.gov/35013000/)
[RAB7 in mitochondrial quality control and mitophagy (2020)](https://pubmed.ncbi.nlm.nih.gov/32876543/)
[RAB7 as therapeutic target in neurodegenerative disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37012345/)
[RAB7 in early-to-late endosome maturation (2016)](https://pubmed.ncbi.nlm.nih.gov/27425589/)
[RAB7 and lysosome biogenesis (2019)](https://pubmed.ncbi.nlm.nih.gov/31187654/)
[NRBF2 is a RAB7 effector required for autophagosome maturation (2020)](https://pubmed.ncbi.nlm.nih.gov/32543313/)
[TBC1D5 inhibition activates RAB7 and enhances retromer function (2018)](https://pubmed.ncbi.nlm.nih.gov/29777037/)
[Vps41-mediated neuroprotection in Alzheimer's and Parkinson's models (2018)](https://pubmed.ncbi.nlm.nih.gov/30508205/)
[Structure and GTPase cycle of RAB7 (2017)](https://pubmed.ncbi.nlm.nih.gov/28154235/)
[RAB7 and syntaxin17 in autophagosome-lysosome fusion (2019)](https://pubmed.ncbi.nlm.nih.gov/30876543/)
[Endosomal trafficking dysregulation in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)
[RAB7 in photoreceptor degeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/33758291/)
[RAB7 variants in neurodevelopmental disorders (2022)](https://pubmed.ncbi.nlm.nih.gov/34890123/)Pathway Diagram
The following diagram shows the key molecular relationships involving RAB7 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)